Services
Growth Innovation Operations
Cases
Insights
AGP Insights Eco Insiders Podcast
About
Contact
EN
中文

Personal Information

Upload Avatar (500 x 500)
Ke Gong
kegong@whu.edu.cn
English, Chinese
Hubei

Academic Information

Wuhan University
Medical School
  • 2003-2007 Bachelor in Biology, Wuhan University
  • 2008-2014 PhD in Cell Biology, Wuhan University
  • 2014-2015 Postdoctoral Researcher, Emory University
  • 2015-2019 Postdoctoral Researcher, University of Texas Southwestern Medical Center
  • 2019-2021 Lecturer, University of Texas Southwestern Medical Center
  • 2021-2022 Distinguished Researcher, Wuhan University
  • 2022-present Professor, Wuhan University
  • 2024-present PI, Wuhan University Life Science Center
  • 2021 Wuhan University Talent Introduction Project
  • 2021 Wuhan 'Wuhan Talent' Outstanding Youth Talent Project
  • 2021 Hubei Province Key Contact Expert
  • 2022 National Talent Project (Execution period: 2023-2025)
  • 2023 National Natural Science Foundation of China (Execution period: 2024-2027)

Research

Tumor cell signaling and targeted molecular mechanisms of resistance in immunotherapy
Database and precision therapy for cancer treatment
  • Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids, Ke Gong, Gao Guo, Nicole A. Beckley, Xiaoyao Yang, Yue Zhang, David E. Gerber, John D. Minna, Sandeep Burma, Dawen Zhao, Esra A. Akbay & Amyn A. Habib, 2021
  • EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer, Ke Gong, Gao Guo, Nishah Panchani, Matthew E. Bender, David E. Gerber, John D. Minna, Farjana Fattah, Boning Gao, Michael Peyton, Kemp Kernstine, Bipasha Mukherjee, Sandeep Burma, Cheng-Ming Chiang, Shanrong Zhang, Adwait Amod Sathe, Chao Xing, Kathryn H. Dao, Dawen Zhao, Esra A. Akbay, and Amyn A. Habib, 2020
Keywords
Egfr Rtk Cancer Genomics Drug Resistance Immunotherapy Precision Medicine Clinical Trials Tumor Microenvironment Signal Transduction Molecular Biology
Related Professors
Xu Binghe - Wuhan University
Area of Focus
Breast Cancer | Malignant Tumors | Molecular Typing | Personalized Treatment | Drug Resistance | Cancer Research | Clinical Trials | Oncology | Medical Science | Treatment Guidelines
Zhihao Wang - Wuhan University
Area of Focus
Lung Cancer | Chemotherapy | Targeted Therapy | Immunotherapy | Radiotherapy | Non-Small Cell | Small Cell | Treatment | Diagnosis | Clinical Trials
Hui Yang - Wuhan University
Area of Focus
Malignant Tumors | Thoracic | Esophageal | Gynecological | Lymphatic Cancers | Radiotherapy | Chemotherapy | Targeted Therapy | Immunotherapy | Clinical Trials
View All
© 2015-2024 Asia Growth Partners Limited | Privacy Policy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.